Atrion (NASDAQ:ATRI – Get Free Report) and GlucoTrack (NASDAQ:GCTK – Get Free Report) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their analyst recommendations, institutional ownership, risk, profitability, valuation, dividends and earnings. Volatility and Risk Atrion has a beta of 0.53, […]
StockNews.com cut shares of Atrion (NASDAQ:ATRI – Free Report) from a hold rating to a sell rating in a research note published on Tuesday morning. Separately, TheStreet lowered shares of Atrion from a b- rating to a c rating in a research note on Monday, May 22nd. Get Our Latest Analysis on ATRI Atrion Trading […]
Atrion Co. (NASDAQ:ATRI – Get Free Report)’s stock price hit a new 52-week low during trading on Friday . The company traded as low as $454.64 and last traded at $454.64, with a volume of 1670 shares changing hands. The stock had previously closed at $462.80. Analyst Upgrades and Downgrades A number of research analysts […]